Seattle Children's Hospital Research Institute  Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on October 12, 2007, 10.1073/pnas.0708293104
PNAS | October 23, 2007 | vol. 104 | no. 43 | 17052-17057


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. T.
Right arrow Articles by Flavell, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. T.
Right arrow Articles by Flavell, R. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

BIOLOGICAL SCIENCES / IMMUNOLOGY
Demethylation of a specific hypersensitive site in the Th2 locus control region

Sean T. Kim*, Patrick E. Fields{dagger}, and Richard A. Flavell*,{ddagger},§

*Department of Immunobiology and {ddagger}Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520; and {dagger}Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160

Contributed by Richard A. Flavell, August 31, 2007 (received for review May 17, 2007)

A growing body of literature has examined and implicated DNA methylation as a critical epigenetic modification in T helper (Th) cell differentiation. The absence of DNA methyltransferases or methyl-binding proteins derepresses many cytokine loci, allowing their ectopic expression, while methylation of specific CpG residues is sufficient to prevent expression. Here, we characterize demethylation events of the Th2 cytokine locus control region (LCR). rad50 hypersensitive site 7 (RHS7), a hypersensitive site within this LCR, becomes demethylated in a STAT6-dependent manner and only in cells stimulated under type 2 conditions. Robust demethylation appears to require signaling contributions from both IL-4 receptor, via STAT6, and CD28, but it cannot be effected by GATA3. Finally, RHS7 is demethylated independently of cell division, consistent with an "active," rather than passive, mechanism. Taken together, these findings firmly connect RHS7 demethylation and Th2 LCR activation in the type 2 differentiation program.

methylation | chromatin | costimulation | cytokine | epigenetics


Author contributions: S.T.K. and P.E.F. designed research; S.T.K. and P.E.F. performed research; R.A.F. contributed new reagents/analytic tools; S.T.K., P.E.F., and R.A.F. analyzed data; and S.T.K. and P.E.F. wrote the paper.

The authors declare no conflict of interest.

§To whom correspondence should be addressed. E-mail: richard.flavell{at}yale.edu

© 2007 by The National Academy of Sciences of the USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?